SANA BAIG: Open Payments
NPI 1124788120 · OCEANSIDE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 74 payments from 14 companies in 2025. Trend: 2023 $28 · 2024 $199 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $269 |
| Madrigal Pharmaceuticals | 9 | $243 |
| ABBVIE INC. | 18 | $231 |
| Lilly USA, LLC | 10 | $110 |
| Ardelyx, Inc. | 4 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| GENZYME CORPORATION | 2 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Novo Nordisk Inc | 2 | $38 |
Products named: TREMFYA, REZDIFFRA, LINZESS, OMVOH, IBSRELA, DUPIXENT, XIFAXAN, ENTYVIO.
Industry payments across NY — which companies pay providers there.
